Search Results - "Praus, M"

Integrated Database of Eight Prospective IgG Studies in Primary Immunodeficiency: New Tool for Pooled Analysis by Rojavin, M.A, Bexon, M, Praus, M, Miede, C, Zenker, O

Get full text

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies by Bajou, Khalid, Masson, Véronique, Gerard, Robert D., Schmitt, Petra M., Albert, Valérie, Praus, Michael, Lund, Leif R., Frandsen, Thomas L., Brunner, Nils, Dano, Keld, Fusenig, Norbert E., Weidle, Ulrich, Carmeliet, Geert, Loskutoff, David, Collen, Desiré, Carmeliet, Peter, Foidart, Jean Michel, Noël, Agnès

“…The plasminogen (Plg)/plasminogen activator (PA) system plays a key role in cancer progression, presumably via mediating extracellular matrix degradation and…”
Get full text

Ksp-cadherin is a functional cell–cell adhesion molecule related to LI-cadherin by Wendeler, M.W, Praus, M, Jung, R, Hecking, M, Metzig, C, Geßner, R

“…Ksp- and LI-cadherin are structurally homologous proteins coexpressed with E-cadherin in renal and intestinal epithelia, respectively. Whereas LI-cadherin has…”
Get full text

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors by PRAUS, M, WAUTERICKX, K, COLLEN, D, GERARD, R

“…Recombinant adenoviral vectors expressing u-PA, t-PA, PAI-1 and PAI-2 were employed to correlate the expression of components of the fibrinolytic system with…”
Get full text

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study by van Schaik, I.N., Bril, V., van Geloven, N., Hartung, H.P., Lewis, R.A., Sobue, G., Lawo, J.P., Praus, M., Mielke, O., Durn, B.L., Cornblath, D.R., Merkies, I.S.J.

Get full text

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens by Harabacz, I, Bock, H, Jüngst, C, Klockmann, U, Praus, M, Weber, R

“…A new, highly purified inactivated tick-borne encephalitis (TBE) vaccine (FSME-Vaccine Behring, BI 71.061) was recently registered in Germany. A multinational…”
Get more information

Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management by KOSTER, Andreas, FISCHER, Thomas, PRAUS, Michael, HABERZETTL, Helmut, KUEBLER, Wolfgang M, HETZER, Roland, KUPPE, Herman

“…Cardiac surgery involving cardiopulmonary bypass (CPB) leads to fulminant activation of the hemostatic-inflammatory system. The authors hypothesized that…”
Get full text

Humoral immunity against tick-borne encephalitis virus following manifest disease and active immunization by Klockmann, U, Bock, H L, Kwasny, H, Praus, M, Cihlová, V, Tomková, E, Krivanec, K

“…Humoral immunity against tick-borne encephalitis virus (TBEV) in patients with a well-documented history of naturally acquired tick-borne encephalitis (TBE)…”
Get more information

Update on the toxicology and pharmacology of rDSPA alpha 1 (Bat-PA) in animals and humans by Gulba, D.C., Praus, M., Dechend, R., Hauck, S., Mahler, M., Zitvz, R., Baldus, B., Müller, W., Dietz, R.

“…The properties of the plasminogen activator of the vampire bat Desmodus rotundus (rDSPA alpha 1), have been studied in both animals and healthy volunteers. In…”
Get full text

Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin by Bosse, Dietrich, Praus, Michaela, Kiessling, Peter, Nyman, Lars, Andresen, Corina, Waters, Joanne, Schindel, Fritz

“…Recombinant human albumin (rHA) is a highly purified animal‐, virus‐, and prion‐free product developed as an alternative to human serum albumin (HSA), to which…”
Get full text

Both u‐PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis by Praus, Michael, Collen, Désiré, Gerard, Robert D.

“…Overexpression of plasminogen activator inhibitor 1 (PAI‐1) reduces tumor cell migration in vitro and metastasis in mice in vivo by mechanisms involving either…”
Get full text

Prion protein stimulates tissue‐type plasminogen activator‐mediated plasmin generation via a lysine‐binding site on kringle 2 by Epple, Guido, Schleuning, Wolf‐Dieter, Kettelgerdes, Gerhard, Kőttgen, Eckart, Geßner, Reinhard, Praus, Michael

“…Recombinant human prion‐protein (PrP23‐231) stimulates plasminogen activation by tissue‐type plasminogen activator (t‐PA). The stimulatory activity is…”
Get full text

The Plasma Supplemented Modified Activated Clotting Time for Monitoring of Heparinization During Cardiopulmonary Bypass: A Pilot Investigation by Koster, Andreas, Despotis, George, Gruendel, Marcus, Fischer, Thomas, Praus, Michael, Kuppe, Herman, Levy, Jerrold H.

“…The standard celite or kaolin activated clotting time (ACT) correlates poorly with heparin levels during cardiopulmonary bypass (CPB). We compared a modified…”
Get full text

Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110 by Praus, Michael, Kettelgerdes, Gerhard, Baier, Michael, Holzhütter, Hermann-Georg, Jungblut, Peter R, Maissen, Manuela, Epple, Guido, Schleuning, Wolf-Dieter, Köttgen, Eckart, Aguzzi, Adriano, Gessner, Reinhard

“…The cellular prion protein (PrP(c)), tissue-type plasminogen activator (t-PA) and plasminogen are expressed in synaptic membranes in vivo. In the central…”
Get more information

Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation by Epple, Guido, Langfeld, Kristina, Baier, Michael, Holzhütter, Hermann-Georg, Schleuning, Wolf-Dieter, Köttgen, Eckart, Gessner, Reinhard, Praus, Michael

“…We have recently shown that the NH(2)-terminal fragment (PrP23-110) of the human cellular prion protein (PrP(c) ) stimulates t-PA mediated plasminogen…”
Get more information

Heparin-Level-Based Anticoagulation Management During Cardiopulmonary Bypass: A Pilot Investigation on the Effects of a Half-Dose Aprotinin Protocol on Postoperative Blood Loss and Hemostatic Activation and Inflammatory Response by Koster, Andreas, Huebler, Sabine, Merkle, Frank, Hentschel, Thomas, Gründel, Marcus, Krabatsch, Thomas, Tambeur, Luc, Praus, Michael, Habazettl, Helmut, Kuebler, Wolfgang M., Kuppe, Hermann

“…Cardiac surgery involving cardiopulmonary bypass (CPB) leads to activation of the hemostatic/inflammatory system. We compared the influence of a half-dose…”
Get full text

Thrombin receptor and urokinase-type plasminogen activator are colocalized in vascular smooth muscle cells derived from human carotid atherosclerotic plaques by Dechend, R., Mo, X., Schulz, W., Gross, M., Praus, M., Dietz, R., Gulba, D.C.

“…Since the u-PA/uPAR system and thrombin are main contributors to the process of proliferation and migration of vascular smooth muscle cells, which is essential…”
Get full text

Efficacy and safety of subcutaneous immunologlobulin replacement therapy at Rome in patients with primary immunodeficiency diseases: Combined analysis of two clinical studies, one in North America and one in Europe by Ochs, HD, Gardulf, A, Praus, M, Kiessling, P

Get full text

The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis by Gross, C Michael, Krämer, Jochen, Pfeufer, Arne, Dietz, Rainer, Gessner, Reinhard, Praus, Michael

“…The principle mechanisms leading to the development of atherosclerosis are long-term accumulation of lipids and cell proliferation. We have recently shown that…”
Get full text

Alert systems for post-marketing surveillance of adverse drug reactions by Praus, M, Schindel, F, Fescharek, R, Schwarz, S

“…When monitoring spontaneous reports of adverse reactions to registered drugs, it is important to detect any change in the number of reported adverse reactions…”
Get more information